Spectrum Thea Pharmaceuticals, the ophthalmic eye care specialists, has appointed adconnection to handle its media planning and buying account.
Commencing on the 30th of June, the campaign will showcase Otrivine, a product for allergy sufferers, with secondary support for Blephasol and Hyabak, for lid hygiene and dry eye, respectively. With a newly structured sales team in the London/Seast area, activity will focus on key outdoor sites in proximity to independent pharmacies in these areas, such as Chiswick, Kensington and Islington.
Press support in the Daily Mail (London/Merdian only) and the Daily Express (National) in the Health Supplement and Editorial sections will push Otrivine in the hayfever season.
Melanie Tymm, Product Manager at Spectrum Thea Pharmaceuticals said: “This will be Spectrum Thea’s first consumer advertising campaign, marking an important and exciting period for the brand. In a competitive market place, it is crucial that we achieve cut through coming into hayfever season. @adconnectionUK performance-based offering and proven success with other pharmaceutical brands made them the obvious choice to handle our media”.
adconnection Account Director, Ellen Birchenough added: “Spectrum Thea’s high quality, diverse range of products make an excellent asset to our expanding client portfolio. With ambitious growth plans for 2014, we are confident that the regionally targeted campaign will be the perfect launching pad for the company, building product recognition and boosting sales at the most opportune time of the year – the height of allergy season”.
For further information, please contact:
Ellen Birchenough, Account Director – adconnection Tel: 020 7401 4830
http://www.adconnection.co.uk/
